Skip to main content

Cost-effectiveness of mandatory bicycle helmet use to prevent traumatic brain injuries and death



Traumatic brain injury (TBI) is the main cause of mortality and severe morbidity in cyclists admitted to Dutch emergency departments (EDs). Although the use of bicycle helmets is an effective way of preventing TBI, this is uncommon in the Netherlands. An option to increase its use is through a legal enforcement. However, little is known about the cost-effectiveness of such mandatory use of helmets in the Dutch context.

The current study aimed to assess the cost-effectiveness of a law that enforces helmet use to reduce TBI and TBI-related mortality.


The cost-effectiveness was estimated through decision tree modelling. In this study, wearing bicycle helmets enforced by law was compared with the current situation of infrequent voluntary helmet use. The total Dutch cycling population, consisting of 13.5 million people, was included in the model. Model data and parameters were obtained from Statistics Netherlands, the National Road Traffic Database, Dutch Injury Surveillance System, and literature. Effects included were numbers of TBI, death, and disability-adjusted life years (DALY). Costs included were healthcare costs, costs of productivity losses, and helmet costs. Sensitivity analysis was performed to assess which parameter had the largest influence on the incremental cost-effectiveness ratio (ICER).


The intervention would lead to an estimated reduction of 2942 cases of TBI and 46 deaths.

Overall, the incremental costs per 1) death averted, 2) per TBI averted, and 3) per DALY averted were estimated at 1) € 2,002,766, 2) € 31,028 and 3) € 28,465, respectively. Most favorable were the incremental costs per DALY in the 65+ age group: € 17,775.


The overall costs per DALY averted surpassed the Dutch willingness to pay threshold value of € 20,000 for cost-effectiveness of preventive interventions. However, the cost per DALY averted for the elderly was below this threshold, indicating that in this age group largest effects can be reached. If the price of a helmet would reduce by 20%, which is non-hypothetical in a situation of large-scale purchases and use of these helmets, the introduction of this regulation would result in an intervention that is almost cost-effective in all age groups.

Peer Review reports


In the Netherlands, cycling is a common mode of transportation and bicycle trips account for up to 28% of all transfers made [1]. Dutch people cycle a mean daily distance of 2.9 km and over 40% of inhabitants cycle at least once a day, the highest level of any country in the European Union [2, 3]. Although the level of road safety in the Netherlands is high, roughly 78,400 injuries per year are treated at an emergency department (ED), of which 13,300 (17%) result in hospital admissions [4]. Even though the total number of bicycle related fatalities declined between 1996 (239) and 2016 (189), the number of bicycle related deaths remained at a high level with an average number of 189 casualties in the last 5 years [5]. In 1996, 20% of all traffic deaths were bicycle related, increasing to 30% in 2016 [5].

Traumatic brain injury (TBI) is the main cause of severe morbidity and mortality after an accident involving bicyclists. More specifically, 32% out of all hospitalized cyclists with severe injury has a head or brain injury [1, 4, 6]. The incidence of bicycle related TBI treated at the ED has increased with 54% between 1998 and 2012, while the overall incidence of bicycle related injuries treated at the ED remained relatively stable in that period. In 2012, bicycle related TBI was treated 43 times per 100,000 persons in the ED and resulted in subsequent hospitalization in 64% of the TBI cases [6].

Most survivors of this form of injury remain impaired for life. TBI has been associated with a decline in cognitive capacity, long lasting physical disability and handicap, and the development of mental illness [7,8,9]. The consequences of TBI often prohibit survivors from returning to full employment, reduce their quality of life, and have been linked to an increased risk of suicide [10,11,12,13]. Scholten et al. valued the mean healthcare costs and costs due to productivity loss resulting from bicycle related TBI at € 19,620 per case for the Netherlands, of which € 4940 healthcare costs and € 14,680 productivity losses per case. Total costs were estimated at 74.5 million euros in 2012 [6].

About 75% of all bicycle-related head injuries are caused by single-bicycle accidents, i.e. accidents without any motorized vehicles involved. In most cases this involves falls or collisions with an obstacle [14]. Polinder et al. (2016) identified these injuries as a priority area for prevention [15]. The use of bicycle helmets has been found to be an effective measure of preventing head and brain injuries, especially in the case of these single-bicycle accidents [16,17,18,19]. It is associated with a 51% reduction in odds for head injury, according to the most recent and comprehensive systematic review on the subject [18]. Several countries have introduced legislation, which enforces the use of helmets. Examples are Spain, Sweden, Australia, New Zealand, certain states in Canada, and the United States [17]. However, many countries only require children to wear helmets. A review of population-based studies that compare injury data before and after the introduction of legislation that enforces use of bicycle helmets found decreases in head injuries and mortality in certain parts of Canada and the United States [17]. However, some other similar studies found only a small or no obvious effect of legislation on number of injuries in New Zealand and certain parts of Australia and Canada [20, 21].

Bicycle helmets are not mandatory in the Netherlands and are generally only used by young children, mountain bikers and racing cyclist [22]. According to a survey commissioned by the Royal Dutch Touring Club, 73% of adults and 84% of children under 17 never wear a helmet [23]. Although a considerable amount of research into the efficacy of both the bicycle helmet and legislation that enforces its use has been performed, the cost-effectiveness of such a law is unknown in the Dutch context. The current research aims to explore the cost-effectiveness of mandatory helmet use by comparing costs and benefits of legislation with the costs and benefits of the existing situation, i.e. voluntary helmet use in a small part of all cyclists. This study can support decision-making concerning a legalization to prevent bicycle related TBI and death [24, 25].


Study design

The cost-effectiveness of legislation that enforces the use of bicycle helmets was assessed through a decision-tree model based on parameters obtained from the literature and several databases. According to the Dutch guideline for economic evaluations, a societal perspective was used, implying that not only healthcare costs but also non-healthcare costs such as cost of lost productivity, were included [26].

The model had a lifetime horizon and compared the cost and effects of the status quo, voluntary helmet use, with the cost and effects of the intervention, mandatory helmet use for all cyclists regardless of age.

In this economic evaluation, behavioral changes as a result of the compulsory wearing of a helmet were not taken into account because conclusive evidence on such behavioral changes were not available.

Study population

The model contained a cohort that consists of all Dutch cyclists that use a non-racing or non-mountain bike, i.e. users of a utility bicycle. It was assumed that users of racing and mountain bikes are also users of the utility bicycle. This type of bicycle is most common for daily use in the Netherlands and will hereafter simply be referred to as ‘bicycle‘. The total number of cyclists was retrieved from Statistics Netherlands [27]. Data on active traffic participants were available for specific age groups in the year 2016 and were corrected for population growth in 2017 (base year) in the corresponding age groups [28]. The resulting total number of approximately 13.5 million cyclists match the raw estimate given by the National Road Traffic Database [29]. Cyclists were divided into three age groups: up to 15 years, between 15 and 65 years, and 65 years and older.

Intervention and comparator

The intervention under analysis is a hypothetical law imposing everyone in the Netherlands to wear a helmet when riding a utility bicycle. The comparator is the current situation of only voluntary helmet use.

Model parameters

  1. a.

    TBI-related disease burden without a helmet law, the current situation

Age specific estimates of bicycle-related TBI incidence and mortality were obtained from the Dutch Injury Surveillance System (LIS) and the mortality statistics of Statistics Netherlands (Table 1) [30, 31]. The LIS is based upon 13 geographically distributed Emergency Departments (EDs) in the Netherlands, resulting in a representative 12% sample of injury-related ED visits. Age specific estimates on DALYs following bicycle related TBI were obtained from the Dutch Burden of Injury Model [32, 33]. These were specified as years lived with disability (YLD) for people that survived bicycle related TBI and years of life lost (YLL) for people that died due to bicycle related TBI. The disability weights for temporary and hospitalized brain injury were 0.090 and 0.241, respectively [34].

Table 1 Model parameters, not specified by age group

All data used from the Dutch Injury Surveillance System, Dutch Burden of injury Model, and national mortality statistics relate specifically to users of utility bicycles in 2017. The annual probability of having TBI was calculated by dividing the incidence of TBI by the total number of cyclist within each age group (≤14, 15–64, ≥65 year). Because of the very low voluntary helmet use in the country, it was assumed that none of the cases with TBI had worn a helmet. The probability of mortality due to bicycle related TBI was calculated by dividing the mortality by the incidence of TBI within each age group.

  1. b.

    Helmet use

An estimate on bicycle helmet efficacy was obtained from a recent and comprehensive review and meta-analysis [18]. As this estimate is presented as an odds ratio (OR), it was recalculated into a relative risk with the following equation: RR = OR (1− Pref) + (Pref OR), where Pref stands for the prevalence of TBI in the group not wearing a helmet [35].

The overall helmet-wearing rate of all injured cyclists that were registered in the Dutch Injury Surveillance System was obtained (2%). This rate was also taken as the helmet-wearing rate in the general population. Estimates on compliance to mandatory bicycle helmet use in other countries were obtained by combining data from literature. Helmet wearing rates following introduction of legislation in New Zealand, Canada, the United States, and Australia were used [21, 36,37,38,39]. In case of several estimates being available for a single country, the mean helmet-wearing rate for that country was calculated. The mean helmet-wearing rate over all countries was added to the helmet-wearing rate in the Netherlands following the introduction of the mandatory helmet for moped drivers in 1975 and the mean of those two variables was considered the projected helmet-wearing rate.

  1. c.

    TBI-related disease burden following legislation

Calculations were as follows:

  • Probability of having TBI for helmet wearers was calculated by multiplying the baseline probability of acquiring TBI as a bicyclist with the relative risk (RR) of TBI for helmet wearers.

  • Incidence of TBI for helmet wearers was obtained by multiplying the projected helmet-wearing rate with the total number of cyclists for a specific age group. This group of helmet wearers was then multiplied with the probability of having TBI for helmet wearers.

  • Incidence of TBI for non-helmet wearers was obtained by multiplying the projected group of non-helmet wearers with the probability of having TBI for non-helmet wearers.

  • Mortality was calculated by multiplying the bicycle related TBI incidence with the probability of mortality due to bicycle related TBI.

  • YLD was calculated by multiplying the YLD in the situation without a helmet law with the ratio of the incidence of TBI in the situation with the helmet law to the incidence of TBI in the situation without the helmet law.

  • YLL was calculated by multiplying the YLL in the situation without a helmet law with the ratio of the mortality in the situation with the helmet law to the mortality in the situation without mandatory helmet use.


The types of costs that were included in the model were healthcare costs, costs due to lost productivity for both people that survived TBI and for people that died from TBI, and the annual cost of purchasing helmets. All costs were expressed in 2017 euros.

  1. a.

    Healthcare costs

Treatment costs of bicycle related TBI were obtained from the Dutch Burden of Injury Model and included general practitioner care, ambulance transport, hospital, physiotherapy, home care and domestic help, nursing homes, and rehabilitation care. These costs occurred within the first year after the injury and were assumed an acceptable representation of the total treatment costs. No data are available for the health care costs after year 1. Total treatment costs for survivors under the helmet law condition were calculated by multiplying the projected incidence of TBI with the mean treatment costs per TBI.

  1. b.

    Productivity losses

The loss of productivity of people that survived TBI were also obtained from the Dutch Burden of Injury Model and were calculated using the friction-cost method, as advised by the Dutch guidelines for health economic evaluation [26]. Only people of working age were eligible to incur this type of cost. The friction cost period was converted into working hours and multiplied by the mean productivity costs per hour for a working person in 2017 [26, 40,41,42]. Total productivity losses for survivors under the helmet law condition are obtained by multiplying the projected incidence of TBI with the mean productivity losses for survivors. Total productivity losses for people that have died were obtained by multiplying the projected mortality with the mean productivity losses for this group.

  1. c.

    Helmet costs

The mean bicycle helmet price was estimated in the same way as was done in German cost-benefit-research [43]. The cost of the cheapest helmet of good quality in the most recent review of ‘Stiftung Warentest’ (consumer product tests) was used and was indexed to Euros 2017 [44,45,46]. The German figures were used because of the large market share and the most recent data.

The mean recommended retail price for the twelve best-selling helmets on was also used. The mean of these two prices was taken and corrected for Dutch price levels [47]. Everyone from the age of fifteen onwards was assumed to wear a helmet for adults. Helmets were assumed to be replaced every 5 years, as this is a period that is cited frequently in other bicycle helmet research [43]. Yearly helmet costs were calculated as one fifth of these total costs. Total helmet costs for the status quo were calculated by multiplying the current percentage of helmet use with the total number of cyclists. Total helmet costs under the helmet law condition were calculated by multiplying the projected helmet-wearing rate with the total number of cyclists for each specific age group, which was then multiplied by the mean helmet price for that age group.


Incremental cost-utility ratios (ICERs) were estimated by dividing the difference in costs between the current situation and the implementation of mandatory bicycle helmet use, by the difference in effects between both scenarios. This means that ICERs were estimated for respectively bicycle related TBI, death, and DALYs averted.

Sensitivity analyses

One way sensitivity analysis was performed to assess the uncertainty surrounding the following model parameters: incidence of TBI, mortality, YLL, disability adjustments in YLD, number of years lived with a disability, costs of healthcare resources use, costs due to productivity loss, annual helmet costs, current helmet wearing percentage, projected future helmet wearing percentage, efficacy of the helmet, and total number of cyclists. The scores were decreased and increased by 20% for each variable separately, except for the projected helmet-wearing rate. This variable was increased to its maximum value of 100%. Results of the sensitivity analyses were displayed in tornado plots. Annual helmet costs were varied with a factor in the range of 10–200%.

Additionally, the human-capital method was used to calculate productivity losses for people that died due to TBI. The use of this method assumes that productivity is lost for the full duration of absence from work until age of retirement, and hence, that costs of productivity losses stretch out over a much longer period than the friction period only [48].. These costs were calculated by subtracting the mean age of death for the group of working age from the retirement age of 65 years and multiplying this with the mean amount of weeks per year, mean working hours per week, net labor participation rate, and mean productivity costs per hour for a working person in 2017. The same was done for the age group younger than 15 years with the same formula, except that they start with a full 50 years of labor left.


Effects and costs that occurred after 1 year were discounted in accordance with the Dutch guideline for economic evaluations [26]. YLL and YLD were discounted at a discount rate of 1.5% per year. Having TBI was assumed not to influence the life expectancy for survivors of TBI, as information about age-specific life expectancy for TBI survivors was not available. Therefore, YLD was discounted for the number of years that the mean person within an age group was projected to live. Productivity losses for people that had died because of bicycle related TBI were only discounted in the sensitivity analysis in which the HC-method was used, because the friction method that was used for the base-case analysis does not extend beyond a 1 year period. A discount rate of 4% per year was used for all costs.


Table 1 shows the values of all variables that were included in the model. The model included 13,468,742 cyclists (see Appendix 1 for age distribution). Implementation of a helmet law was projected to lead to a helmet wearing rate of 88% and helmet wearers were assumed to have a relative risk for TBI of 0.583 (CI95 0.513–0.658).


In 2017, 8016 cases of TBI were registered in Dutch EDs among users of utility bicycles (Table 2), of which 124 died. TBI per 100,000 inhabitants was approximately twice as high in people of 65 years and older, compared to other age groups. Mortality per 100,000 inhabitants was also highest in people of 65 years and older with a mortality rate that was fifteen and eight-fold higher than in people under 15 years of age and people between 15 and 65 years, respectively. The total burden of TBI related disease was 11,746 DALYs (2.620 LYL and 9.126 YLD) The burden of disease relative to the incidence of TBI was highest in people under 15 years due to a relatively high number of YLD. The bottom part of Table 2 displays the projections of incidence of TBI and subsequent mortality for cyclists after implementation of a helmet law.

Table 2 Yearly bicycle related TBI, subsequent mortality and related disease burden in the Netherlands without a helmet law (top), with a helmet law (middle) and the difference between these scenarios (bottom). Undiscounted figures

The introduction of a helmet law is projected to lead to a yearly reduction of 2942 cases of TBI and 46 deaths across all age groups (Table 2). The number needed to treat for TBI was 4029 for the overall age group. Overall disease burden was reduced by 4310 DALYs, most of which were averted in people between the age of 15 and 65 years (Table 2).


The decrease in TBI leads to approximate annual mean savings of 12.8 million euros in medical costs and 11.8 million euros due to averted productivity losses. However, total annual depreciated spending on bicycle helmets rose with approximately 116 million euros, which lead to incremental cost of more than 91 million euros (see Fig. 1).

Fig. 1

Overview of total costs per scenario and spending per cost-type


Table 3 shows that there was a large fluctuation in cost-effectiveness between the age groups, with the ICERs for cost per TBI prevented, cost per death prevented, and cost per DALY averted being most favourable for people of 65 years and older, € 17,775 per DALY. Cost per TBI and death prevented were highest for people aged 14 and younger (€ 19,152,803 and € 10,676, 247), while cost per DALY averted was highest in the middle age group (€ 40,519). Overall, the costs per death averted were estimated at € 22,002,76, per TBI averted € 31,028, and per DALY € 28,465. Use of the human-capital approach for calculating the loss of productivity leads to cost-effectiveness estimates being approximately 10% lower for the youngest age group and 15% lower for the middle age group, when compared to the use of the friction-costs method (Appendix 2).

Table 3 Overview of incremental cost-effectiveness ratios, friction-costs method. Discounted figures

Sensitivity analyses

The sensitivity analyses revealed that the parameter value for helmet efficacy had the largest influence on the ICER. A 20% increase in efficacy lowered the cost per DALY to around € 20,000 and a 20% decrease raised the costs per DALY to around € 42,000 for the overall group (Fig. 2). Total number of cyclists, the annual-helmet costs and incidence of TBI were additional variables that influence results to a large degree. These variables influenced the ICER of the age group of people aged 65 years and older sufficiently for them to possibly surpass the threshold value of € 20,000 per DALY (Fig. 2). Pre- and post-law helmet-wearing rates barely influenced the results. Figure 3 shows that decreasing the annual helmet costs to 2/3rd of the standard helmet costs would also lead to cost-effectiveness for the age groups 0–14 and 15–64 years.

Fig. 2

Results of one-way sensitivity analyses for the ICER of cost per DALY averted in the overall group (above) and the age group above 65 years (below)

Fig. 3

Cost per DALY as a function of annual helmet costs in the range of 10–200% of the standard helmet costs


The current study aimed to assess the cost-effectiveness of enforcing bicycle helmet use through legislation as a means of preventing bicycle related TBI and mortality in the Netherlands [49, 50]. Without considering different age groups, the current intervention is not cost-effective in light of the Dutch reference value for cost-effectiveness of € 20,000 per QALY [50]. However, the results show a large fluctuation in cost-effectiveness between age groups. It is notable that all ICERs are most favorable in people aged 65 years or older, despite the fact that this group incurred no costs for lost productivity due to retirement. The absence of savings related to productivity losses was offset by a substantially higher incidence rate and higher mean medical costs when compared to the other groups (Table 2 and Appendix 3). This age group is the only group with an ICER per DALY averted that is below the threshold of € 20,000. In addition, the ICER per death prevented is approximately 26 and 11 times lower as for the youngest and middle age group, respectively.

As no Dutch utility figures for injuries associated with traffic accidents were available, we choose to use disability figures for injuries and DALY outcomes in our analysis. Although use of DALY as an outcome measure in economic evaluations is less common than use of QALYs, it is accepted as well, as appeared from a review of Oostvogels et al. [51]. Therefore, the intended health effect is expressed as DALYs averted following mandatory helmet use. Both QALY and DALY are a form of health-adjusted life expectancy (HALE). The primary difference between the two outcome measures is that QALYs primarily measure health gains following interventions, while DALYs measure health losses from disease and death [52]. Another difference is that DALYs, by adjusting life years for disability caused by one single health problem such as TBI, do not consider comorbidity and thus tend to be relatively larger than QALYs when comorbidity is present. Therefore, use of DALYs could lead to an overestimation of the disease burden [52] and a somewhat flattered ICER. In absence of a clear threshold value in the Netherlands for cost-effectiveness when DALYs are used as outcome measure, we chose to use the same threshold value for DALYs as is commonly used for QALYs in the Netherlands, namely € 20,000 [50]. This threshold value is much more stringent than the WHO guidelines on cost-effectiveness that state that any intervention with a cost-effectiveness ratio below the GDP per capita (€ 43,100 for the Netherlands in 2017) should be regarded as a cost-effective intervention. Should we have followed this standard, our conclusions on cost-effectiveness of mandatory helmet use would have been more positive than they currently are.

When interpreting the results, it should be remembered that we chose not to include the often cited substitution effect and risk compensation effect in our analysis [53, 54] . The former is related to the fact that mandatory helmet use could discourage current cyclists to use bicycles but other forms of transportation instead for (part of) their journeys [53, 54]. The latter is said to increase risk for injury by increased risk taking behavior by either the helmet wearing cyclists themselves or by other traffic participants [55, 56]. However, both mechanisms are not undisputed either [57]. We decided not to include these factors in our model, due to their uncertain nature. Nonetheless, we should bear in mind that the possible presence of substitution and risk compensation effects could have led to less favorable cost-effectiveness estimates.

Our findings are in line with the existing literature. However, most previous economic evaluations of helmet laws have used cost-benefit methods rather than cost-effectiveness analysis [36, 43]. Economic evaluations that use a societal perspective of costs generally agree that a helmet law is not beneficial, i.e. that the costs outweigh the associated benefits [43]. Although many studies evaluate the effectiveness of bicycle helmet laws, not many evaluate their cost-effectiveness. To our knowledge, no contribution has been made to this field in the last two decades. In one of the few papers on cost-effectiveness, Hendrie et al. focused on the cost of public education campaigns and police enforcement and not on medical costs and productivity losses [38]. They did however measure the cost of purchasing helmets, which was also by far their largest cost item. They estimated the cost per TBI prevented to be € 99,123 for their aggregated data model and € 212,769 for their individual pooled data model [38]. This is substantially higher than the €31,028 per TBI prevented that we found, probably mainly because they did not consider the healthcare savings associated with less TBI. In another cost-effectiveness paper, cost per (discounted) life saved was estimated to between € 85,727 to € 110,332 for children from 5 to 12 years, between € 673,193 to € 793,338 for children from 13 to 18 years old and between € 863,340 to € 984,404 for adults [58]. This is substantially lower than the estimates that we found. Interestingly, the cost per death averted in this study is higher for adults than it is for children, while we found an inverse relationship. The most recent cost-effectiveness research was done in 2000 by Kopjar & Wickizer, and found the same age gradient [59]. They found the risk of head injury and the largest reduction in absolute risk of head injury due to wearing a helmet to be the highest in children. We found the opposite. Our data clearly show that, in the Netherlands, 0.115% of all people older than 65 years had TBI in 2017, while only 0.050% of children under 15 years was admitted to an Emergency Department with this type of trauma. This might be because the cycling infrastructure in the Netherlands gives this age group a feeling of safety, while they are in fact more vulnerable [60]. To our knowledge, no other research has looked at the cost per DALY averted or QALY gained to date.

Results of the sensitivity analyses show that the ICERs were most influenced by the efficacy of bicycle helmet use that was assumed in the model. The efficacy of bicycle helmets is often debated in the scientific literature [18, 61,62,63]. Generally, two types of research have been performed. Firstly, case-control studies, in which brain damage between people that did and did not wear a helmet is compared, and secondly, ecological studies, in which the period before and after the introduction of an intervention to stimulate helmet use is compared. Case-control studies tend to find a higher efficacy of bicycle helmets than time series analysis [64]. Both types of research are vulnerable to confounding factors in their own regard. The meta-analysis by Olivier et al. that was used in this study includes recent research from several countries over several years and was therefore the best available study [18]. Additionally, they checked for evidence of time trends and publication bias, which they did not find. Therefore, this meta-analysis was deemed more comprehensive and likely more fitting the Dutch context, as opposed to results from ecological studies, which generally relate to developments over time in one specific country.

In the Netherlands, the share of electric bicycles out of all newly sold bikes rose from 15% in 2011 to 31% in 2017 [65]. According to the Dutch cyclists’ federation, about 6% of all bicycles in the Netherlands are electric bicycles [66]. However, more than a quarter of all bicycle related deaths were related to use of electric bicycles. Out of these deaths, three quarters are people aged 65 years and older [67]. The relatively high mortality under users of electric bicycles hints to a high incidence of TBI in this group. Therefore, users of electric bicycles seem to be a very relevant group for the intervention under study. Unfortunately, the EDs in the Netherlands do not systematically register the use of an electric bicycle by patients admitted with TBI. Hence, we could not stratify for the use of electric bicycles in our research, while we know that between 2010 and 2017 there was an increase of the selling of new e-bikes of 77%.

Strengths of this study

The main strength of the study lies in the use of recent data regarding incidence, medical costs, and disease burden from the Dutch Injury Surveillance System and Dutch Burden of Injury Model. Therefore, to our knowledge, this is the first paper that reports the disease burden of bicycle related TBI in DALYs and the societal costs associated with preventing them.

Limitations of this study

The availability of data used in this research restricted us from performing probabilistic sensitivity analysis (PSA). PSA would have resulted in more reliable and specific ICERs by adding information about the distribution of the model parameters. However, information about the distribution was unavailable for a large number of parameters. The probability of TBI is unrelated to the intensity of bicycle use, while those who cycle more are at greater exposure to TBI risk than those who rarely use a bike. No data are available about bike use intensity. Unfortunately, data on electric bicycles use were not available so we could not distinguish this group of cyclists in this economic evaluation. The fact that we only had healthcare costs available for the first year leads to an underestimation of the cost-effectiveness of the use. Finally, we did not include police enforcement and regulation costs in our study, due to data limitations. The ICERs as estimated in this study may be less beneficial when these costs would have been taken into account. On the other hand, the fact that we only included TBI and not all other injury costs, such as related to fractures, nor other costs of accidents, such as material damage and indirect costs of traffic jams, may have prevented us from reporting more favorable ICERs.

Our results are specific for the Dutch cycling context and, as a consequence, not directly transferable to other countries’ settings. First, in the Netherlands cycling is much more common than in other European countries, Denmark excluded. The infrastructure with cycle lanes and other traffic aspects, such as right of way for cyclists and legal responsibility of motorized traffic in any traffic accident, regardless of actual responsibility, differs enormously from other countries. Consequently, injury risks differ substantially, independent of helmet use. Second, in the Netherlands most cyclist currently do not wear a helmet, whereas in most other countries helmet use is common.


The current research shows that a law that enforces the use of bicycle helmets for every age group is not cost-effective with an ICER of €28,465 per DALY averted which is higher than the accepted Dutch reference value for cost-effectiveness of preventive interventions. With respect to the difference between age groups, we found this intervention to be cost-effective for people aged 65 years and over due to their relatively high risk of getting TBI with an ICER of €17,775 per DALY averted. One must realize that the costs of the intervention are primarily paid by the individual citizen and the revenues are mainly for the whole society. The acquisition of helmets proved to be an important cost item. If the price of a helmet reduces with 20%, which is a possibility due to large-scale purchases and use of these helmets, the introduction of this regulation would result in an intervention that is approximately cost-effective for all age groups. As this is the first study in the Netherlands that evaluates the cost-effectiveness of enforcing helmet use for cyclists, this can add to the debate around regulating helmet use in general and more specifically for the elderly. We recommend future research towards the mechanisms behind the increased cycling risks for the elderly and the acceptability of a helmet law. We also advise to make the registration of the use of an electric bicycle at the ED standard practice, as the electric bicycle is likely to have an increasing and significant role in TBI. To conclude, although Dutch society is at present not very enthusiastic to wear bicycle helmets, a law that enforces helmet use may be an effective and also cost-effective intervention, certainly in the elderly.

Availability of data and materials

All data and materials from Statistics Netherlands, the National Road Traffic Database and the Dutch Injury Surveillance System used in the model are freely available by contacting the corresponding author:



Disability adjusted life year


Emergency department


Incremental cost-effectiveness ratio


Injury surveillance system


Odds ratio


Probabilistic sensitivity analysis


Relative risk


Traumatic brain injury


Life years lived with a disability


Years of life lost


  1. 1.

    People mobility in the Netherlands; transport modes and travel motives, regions. [Personenmobiliteit in Nederland; vervoerwijzen en reismotieven, regio's] [Internet]. CBS. 2017 [cited 26-04-2018]. Available from:,6&d4=0-1&d5=0,2&d6=4–5&hd=160923–0938&hdr=t&stb=g1,g4,g3,g2,g5.

  2. 2.

    Statistics Netherlands (CBS), National Institute for Public Health and the Environment (RIVM), BOVAG-RAI, GFK Panel Services, Dutch Cyclists Union. Factsheet The Netherlands: cycling country. [Factsheet Nederland fietsland] 2015. Available from:

    Google Scholar 

  3. 3.

    European Commission. Special Eurobarometer 406: attitudes of Europeans towards urban mobility. European Commission; 2013.

    Google Scholar 

  4. 4.

    VeiligheidNL. Traffic accidents 2014. [Verkeersongevallen 2014]. Amsterdam: VeiligheidNL; 2016.

    Google Scholar 

  5. 5.

    Deceased people; death by traffic accident in the Netherlands, manner of participation. [Overledenen; doden door verkeersongeval in Nederland, wijze van deelname] [Internet]. CBS. 2018 [cited 26-04-2018]. Available from:,2&D2=0&D3=a&D4=a&HDR=G1,T&STB=G2,G3&VW=T.

  6. 6.

    Scholten AC, Polinder S, Panneman MJ, van Beeck EF, Haagsma JA. Incidence and costs of bicycle-related traumatic brain injuries in the Netherlands. Accid Anal Prev. 2015;81:51–60.

    Article  Google Scholar 

  7. 7.

    Andelic N, Hammergren N, Bautz-Holter E, Sveen U, Brunborg C, Roe C. Functional outcome and health-related quality of life 10 years after moderate-to-severe traumatic brain injury. Acta Neurol Scand. 2009;120(1):16–23.

    Article  CAS  Google Scholar 

  8. 8.

    Masson F, Vecsey J, Salmi LR, Dartigues JF, Erny P, Maurette P. Disability and handicap 5 years after a head injury: a population-based study. J Clin Epidemiol. 1997;50(5):595–601.

    Article  CAS  Google Scholar 

  9. 9.

    Deb S, Lyons I, Koutzoukis C, Ali I, McCarthy G. Rate of psychiatric illness 1 year after traumatic brain injury. Am J Psychiatry. 1999;156(3):374–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir. 2006;148(3):255–68 discussion 68.

    Article  CAS  Google Scholar 

  11. 11.

    Holtslag HR, Post MW, van der Werken C, Lindeman E. Return to work after major trauma. Clin Rehabil. 2007;21(4):373–83.

    Article  Google Scholar 

  12. 12.

    Teasdale TW, Engberg AW. Suicide after traumatic brain injury: a population study. J Neurol Neurosurg Psychiatry. 2001;71(4):436–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. 13.

    van Zomeren AH, van den Burg W. Residual complaints of patients two years after severe head injury. J Neurol Neurosurg Psychiatry. 1985;48(1):21–8.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Institute for Road Safety Research (SWOV). Bicycle helmets. SWOV-factsheet. [Fietshelmen. SWOV-factsheet]. Leidschendam: SWOV; 2011.

    Google Scholar 

  15. 15.

    Polinder S, Haagsma J, Panneman M, Scholten A, Brugmans M, Van Beeck E. The economic burden of injury: health care and productivity costs of injuries in the Netherlands. Accid Anal Prev. 2016;93:92–100.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Kemler HJ, Ormel W, Jonkhoff L, Klein Wolt K, Veling M, Buuron I, Meijer C. The bicycle helmet for children and young people. Research into the advantages and disadvantages. [De fietshelm bij kinderen en jongeren. Onderzoek naar de voor- en nadelen]. Amsterdam: Consumer and Safety Institute; 2009.

    Google Scholar 

  17. 17.

    Macpherson A, Spinks A. Bicycle helmet legislation for the uptake of helmet use and prevention of head injuries. Cochrane Database Syst Rev. 2008;3:CD005401.

    Google Scholar 

  18. 18.

    Olivier J, Creighton P. Bicycle injuries and helmet use: a systematic review and meta-analysis. Int J Epidemiol. 2017;46(1):278–92.

    PubMed  PubMed Central  Google Scholar 

  19. 19.

    Thompson DC, Rivara FP, Thompson R. Helmets for preventing head and facial injuries in bicyclists. Cochrane Database Syst Rev. 2000;2:Cd001855.

    Google Scholar 

  20. 20.

    Dennis J, Ramsay T, Turgeon AF, Zarychanski R. Helmet legislation and admissions to hospital for cycling related head injuries in Canadian provinces and territories: interrupted time series analysis. BMJ. 2013;346:f2674.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Robinson DL. No clear evidence from countries that have enforced the wearing of helmets. BMJ. 2006;332(7543):722–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Scholten AC, Haagsma JA, Panneman MJ, van Beeck EF, Polinder S. Traumatic brain injury in the Netherlands: incidence, costs and disability-adjusted life years. PLoS One. 2014;9(10):e110905.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Meer P.A.M. van der. Research report on bicycle behavior in the Netherlands [Onderzoeksverslag Fietsgedrag in Nederland]. TerraKnowledge; 2014.

  24. 24.

    Hutton G. Economic evaluation of environmental health interventions to support decision making. Environ Health Insights. 2008;2:137–55.

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Robinson R. Economic evaluation and health care. What does it mean? BMJ. 1993;307(6905):670–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. 26.

    ZIN. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. Amsterdam: Zorginstituut Nederland (ZIN); 2015.

    Google Scholar 

  27. 27.

    People mobility; share of road users according to personal characteristics. [Personenmobiliteit; aandeel van verkeersdeelnemers naar persoonskenmerken] [Internet]. CBS. 2018 [cited 14-05-2018]. Available from:

  28. 28.

    Population; sex, age and marital status, 1 January. [Bevolking; geslacht, leeftijd en burgerlijke staat, 1 januari] [Internet]. CBS. 2018 [cited 01-06-2018]. Available from:

  29. 29.

    van de Ven T. Market consultation floating bicycle data [Marktconsultatie floating bicycle data]. Nationale Databank Wegverkeersgegevens; 2017.

    Google Scholar 

  30. 30.

    (CBS) SN. More fatalities on the bike than in the car in 2017. [In 2017 meer verkeersdoden op de fiets dan in de auto]: CBS; 2018 [[01-08-2016]]. Available from:

  31. 31.

    Mulder S, Meerding WJ, Van Beeck EF. Setting priorities in injury prevention: the application of an incidence based cost model. Injury Prev. 2002;8(1):74–8.

    Article  CAS  Google Scholar 

  32. 32.

    Polinder S, Haagsma JA, Bonsel G, Essink-Bot ML, Toet H, van Beeck EF. The measurement of long-term health-related quality of life after injury: comparison of EQ-5D and the health utilities index. Injury Prev. 2010;16(3):147–53.

    Article  Google Scholar 

  33. 33.

    Polinder S, van Beeck EF, Essink-Bot ML, Toet H, Looman CW, Mulder S, et al. Functional outcome at 2.5, 5, 9, and 24 months after injury in the Netherlands. J Trauma. 2007;62(1):133–41.

    Article  Google Scholar 

  34. 34.

    Haagsma JA, Polinder S, Lyons RA, Lund J, Ditsuwan V, Prinsloo M, et al. Improved and standardized method for assessing years lived with disability after injury. Bull World Health Organ. 2012;90(7):513–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Zhang J, Kai FY. What’s the relative risk?: a method of correcting the odds ratio in cohort studies of common outcomes. Jama. 1998;280(19):1690–1.

    Article  CAS  Google Scholar 

  36. 36.

    Taylor M, Scuffham P. New Zealand bicycle helmet law—do the costs outweigh the benefits? Injury Prevention. 2002;8(4):317–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Carr DJ, Cameron M, Skalova M. Evaluation of the bicycle helmet wearing law in Victoria during its first four years: Monash University, Accident Research Centre; 1995.

    Google Scholar 

  38. 38.

    Hendrie D, Legge M, Rosman D, Kirov C. An economic evaluation of the mandatory bicycle helmet legislation in Western Australia. Conference on Road Safety, Perth, Western Australia, November; 1999.

    Google Scholar 

  39. 39.

    Marshall J, White M. Evaluation of the compulsory helmet wearing legislation for bicyclists in South Australia: Office of Road Safety; 1994.

    Google Scholar 

  40. 40.

    Working population; labor duration. [Werkzame beroepsbevolking; arbeids duur] [Internet]. CBS. 2018 [cited 10-06-2018]. Available from:,3-7,9&D2=a&D3=0&D4=64,69,74&HDR=G3,T&STB=G1,G2&VW=T.

  41. 41.

    Labor participation; key figures. [Arbeidsdeelname; kerncijfers] [Internet]. CBS. 2018 [cited 15-07-2018]. Available from:,T&STB=G2,G3,G4&VW=T.

  42. 42.

    Consumer prices; price index 2015 = 100. [Consumentenprijzen; prijsindex 2015=100] [Internet]. CBS. 2018 [cited 15-06-2018]. Available from:,259,272,285&HDR=T&STB=G1,G2&VW=T.

  43. 43.

    Sieg G. Costs and benefits of a bicycle helmet law for Germany. Transportation. 2016;43(5):935–49.

    Article  Google Scholar 

  44. 44.

    For knights on wheels. [Für Ritter auf Rädern]. Stiftung Warentest. 2016(6):78–83.

  45. 45.

    Safe shock absorbers [Sichere Stoßdämpfer]. Stiftung Warentest. 2017(5):65–9.

  46. 46.

    Consumer prices - Annual inflation, All items non-food non-energy [Internet]. OECD. 2018 [cited 15-06-2018]. Available from:

  47. 47.

    Monthly comparative price levels [Internet]. OECD. 2018 [cited 17-06-2018]. Available from: DataSetCode=CPL.

  48. 48.

    Van den Hout W. The value of productivity: human-capital versus friction-cost method. Ann Rheum Dis. 2010;69(Suppl 1):i89–91.

    Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Suijkerbuijk AW, van Gils PF, Greeven PG, de Wit GA. Cost-effectiveness of addiction care. [De kosteneffectiviteit van interventies gericht op verslaving aan alcohol en drugs]. Tijdschr Voor Psychiatrie. 2015;57:498–507.

    CAS  Google Scholar 

  50. 50.

    van den Berg M, de Wit GA, Vijgen SM, Busch MC, Schuit AJ. Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands. [Kosteneffectiviteit van preventie: kansen voor het Nederlandse volksgezondheidsbeleid]. Ned Tijdschr Geneeskd. 2008;152(23):1329–34.

    PubMed  Google Scholar 

  51. 51.

    Oostvogels AJ, De Wit GA, Jahn B, Cassini A, Colzani E, De Waure C, et al. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review. Epidemiol Infect. 2015;143(9):1791–802.

    Article  CAS  Google Scholar 

  52. 52.

    Gold MR, Stevenson D, Fryback DG. HALYs and QALYs and DALYs, oh my: similarities and differences in summary measures of population health. Annu Rev Public Health. 2002;23(1):115–34.

    Article  Google Scholar 

  53. 53.

    Olivier J, Churches T, Walter S, McIntosh A, Grzebieta R. Response to Rissel and Wen: The possible effect on frequency of cycling if mandatory bicycle helmet legislation was repealed in Sydney, Australia: a cross sectional survey? Health Prom J Australia. 2012;23(1):76.

    Article  Google Scholar 

  54. 54.

    Rissel C, Wen LM. The possible effect on frequency of cycling if mandatory bicycle helmet legislation was repealed in Sydney, Australia: a cross sectional survey. Health Prom J Australia. 2011;22(3):178–83.

    Article  Google Scholar 

  55. 55.

    Phillips RO, Fyhri A, Sagberg F. Risk compensation and bicycle helmets. Risk Analysis. 2011;31(8):1187–95.

    Article  Google Scholar 

  56. 56.

    Walker I. Drivers overtaking bicyclists: objective data on the effects of riding position, helmet use, vehicle type and apparent gender. Accid Anal Prev. 2007;39(2):417–25.

    Article  Google Scholar 

  57. 57.

    Olivier J, Wang JJ, Walter S, Grzebieta R. Anti-helmet arguments: lies, damned lies and flawed statistics. J Australasian College of Road Safety. 2014;25(4):10.

    Google Scholar 

  58. 58.

    Hansen P, Scuffham PA. The cost-effectiveness of compulsory bicycle helmets in New Zealand. Aust J Public Health. 1995;19(5):450–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Kopjar B, Wickizer TM. Age gradient in the cost-effectiveness of bicycle helmets. Prev Med. 2000;30(5):401–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. 60.

    Pucher J, Buehler R. Making cycling irresistible: lessons from the Netherlands. Denmark and Germany Transport Rev. 2008;28(4):495–528.

    Google Scholar 

  61. 61.

    Attewell RG, Glase K, McFadden M. Bicycle helmet efficacy: a meta-analysis. Accid Anal Prev. 2001;33(3):345–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. 62.

    Curnow WJ. The efficacy of bicycle helmets against brain injury. Accid Anal Prev. 2003;35(2):287–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Fahlstedt M, Halldin P, Kleiven S. The protective effect of a helmet in three bicycle accidents--a finite element study. Accid Anal Prev. 2016;91:135–43.

    Article  PubMed  PubMed Central  Google Scholar 

  64. 64.

    Elvik R. Publication bias and time-trend bias in meta-analysis of bicycle helmet efficacy: a re-analysis of Attewell, Glase and McFadden, 2001. Accid Anal Prev. 2011;43(3):1245–51.

    Article  PubMed  PubMed Central  Google Scholar 

  65. 65.

    RAI/BOVAG/GfK. Total report Market figures Cycling 2007–2017 [Totaalrapportage Marktcijfers Fietsen 2007–2017].

  66. 66.

    Fietsersbond. Cycling in numbers. [Fietsen in cijfers] Utrecht: Fietsersbond; 2018 [01-08-2018]. Available from:

  67. 67.

    Statistics Netherlands (CBS). More fatalities on the bicycle than in the car in 2017. [In 2017 meer verkeersdoden op de fiets dan in de auto]: CBS; [updated 25-04-2018]. Available from:

Download references


We thank Martien Panneman of for providing injury data.


Funding was received from the National Institute for Public Health.

Author information




RR, AWMS, PFVG and EABO developed the method of the study. RR, AWMS, PFVG, EABO, JJP and GADW helped to draft the manuscript, read and approved the final manuscript. For RR, this research was the graduation assignment of the MSc Health Sciences of the Vrije Universiteit in Amsterdam.

Corresponding author

Correspondence to Paul F. van Gils.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Appendix 1

Table 4 Number of cyclists by age group

Appendix 2

Table 5 Overview of incremental cost-effectiveness ratios, human-capital method

Appendix 3

Table 6 Mean healthcare costs

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Reuvers, R., Over, E.A.B., Suijkerbuijk, A.W.M. et al. Cost-effectiveness of mandatory bicycle helmet use to prevent traumatic brain injuries and death. BMC Public Health 20, 413 (2020).

Download citation


  • Bicycle helmet use
  • Cost-effectiveness
  • Traumatic brain injury
  • Economic evaluation
  • The Netherlands